PALS Provider: Course

Incorrect. Hypoxia is the leading cause of pediatric bradycardia and should be addressed with oxygenation and ventilation.

Incorrect. Epinephrine is given at a dose of 0.01 mg/kg IV every 3-5 minutes for pediatric bradycardia unresponsive to oxygenation.

Incorrect. Fluid resuscitation restores perfusion, and antibiotics address the infection causing septic shock.

Incorrect. The total cumulative dose of amiodarone should not exceed 15 mg/kg to avoid toxicity during cardiac arrest resuscitation.

Incorrect. Respiratory failure is the leading cause of cardiac arrest in children due to their dependency on oxygenation and ventilation.

Incorrect. The recommended compression rate for high-quality CPR in children is 100-120 compressions per minute.

Incorrect. Magnesium sulfate is the treatment of choice for torsades de pointes and is not contraindicated.

Incorrect. Amiodarone is administered at 5 mg/kg IV/IO during pediatric cardiac arrest for refractory VF or pulseless VT.

Incorrect. Synchronized cardioversion is indicated in unstable SVT to restore a normal sinus rhythm safely.

Incorrect. Assessing responsiveness determines whether the child requires immediate intervention.

Incorrect. The two-thumb encircling technique ensures effective compressions and promotes high-quality infant CPR.

Incorrect. The jaw thrust maneuver protects the cervical spine while ensuring an open airway for effective ventilation.

Incorrect. The first-line treatment for bradycardia caused by hypoxia is oxygenation and ventilation; atropine is used if bradycardia persists.

Incorrect. Hypoglycemia is a reversible cause of PEA and should be corrected to restore normal metabolic and cardiac function.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the drug of choice for torsades de pointes.

Incorrect. Oxygen improves oxygenation and stabilizes respiratory function in children with severe distress.

Incorrect. Neonates in shock or with hypovolemia should receive a fluid bolus of 10 mL/kg of isotonic crystalloid.

Incorrect. Switching roles every 2 minutes prevents rescuer fatigue and ensures high-quality chest compressions.

Incorrect. By 10 minutes after birth, neonates should reach an oxygen saturation of 90-95%, reflecting effective oxygenation.

Incorrect. Maintaining oxygen saturation between 90-95% prevents hypoxia and avoids the risks of hyperoxia in neonates.

Incorrect. Neonates achieve oxygen saturation of 80-85% within the first 5 minutes as oxygenation gradually improves after birth.

Incorrect. Asystole is a non-shockable rhythm requiring high-quality CPR and epinephrine administration.

Incorrect. Magnesium sulfate stabilizes cardiac cells and is the treatment of choice for torsades de pointes.

Incorrect. PEA is a non-shockable rhythm and is managed with high-quality CPR, epinephrine, and addressing reversible causes.

Incorrect. Magnesium sulfate is the treatment of choice for torsades de pointes in pediatric patients, not lidocaine.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. Magnesium sulfate is the drug of choice for stabilizing cardiac cells in torsades de pointes.

Incorrect. Waveform capnography is the most reliable method to confirm and monitor endotracheal tube placement during resuscitation.

Incorrect. Epinephrine is used to improve perfusion and heart rate in symptomatic bradycardia unresponsive to oxygen.

Incorrect. ROSC refers to the restoration of spontaneous cardiac activity with a detectable pulse and effective circulation.

Incorrect. Compressing one-third the chest depth ensures effective perfusion while minimizing the risk of injury in children.

Incorrect. Rescue breaths deliver oxygen to maintain adequate ventilation in children with respiratory arrest and a pulse.

Incorrect. Tension pneumothorax is a treatable cause of cardiac arrest, managed by needle decompression to relieve intrathoracic pressure.

Incorrect. The first defibrillation dose for pediatric pulseless VT starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks.

Incorrect. Rescue breaths ensure oxygenation and prevent further deterioration in children with respiratory failure.

Incorrect. Oxygen improves perfusion and is the first-line treatment for bradycardia caused by hypoxia.

Incorrect. Lidocaine should not exceed a total dose of 3 mg/kg to avoid toxicity during pediatric resuscitation.

Incorrect. Oxygen is administered to stabilize respiratory failure and improve oxygen delivery.

Incorrect. Nebulized epinephrine reduces airway swelling and improves airflow in children with severe croup.

Incorrect. Pediatric defibrillation starts at 2 J/kg and may increase to 4 J/kg for subsequent shocks if needed.

Incorrect. Epinephrine is given every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Oxygenation and ventilation are the first-line treatments for pediatric bradycardia, addressing the most common cause: hypoxia.

Incorrect. The maximum cumulative dose of amiodarone in pediatric cardiac arrest is 15 mg/kg, given in divided doses.

Incorrect. The defibrillation dose increases to 4 J/kg for refractory VF after the initial 2 J/kg shock.

Incorrect. Neonates transition to higher oxygen saturation levels gradually, targeting 80-85% by 5 minutes of life.

Incorrect. Fowler’s position (sitting upright) helps reduce respiratory effort and improve ventilation in children with breathing difficulties.

Incorrect. Rescue breaths provide adequate oxygenation for children with a pulse but insufficient respiratory effort.

Incorrect. Epinephrine is administered at 0.01 mg/kg IV/IO every 3-5 minutes during neonatal resuscitation.

Incorrect. The cumulative maximum dose of amiodarone in pediatric cardiac arrest is 15 mg/kg IV/IO, given in divided doses.

Incorrect. Epinephrine is given every 3-5 minutes at 0.01 mg/kg IV/IO to improve perfusion during cardiac arrest.

Incorrect. Maintaining oxygen saturation at 94-98% avoids both hypoxia and the harmful effects of hyperoxia.

Incorrect. Vagal maneuvers are the first-line treatment to terminate SVT in stable pediatric patients by increasing vagal tone.

Incorrect. Encouraging spontaneous clearance prevents worsening of the obstruction in children with partial airway blockage.

Incorrect. Epinephrine is the drug of choice for treating bradycardia when oxygenation and ventilation do not resolve the issue.

Incorrect. The total dose of amiodarone during pediatric cardiac arrest should not exceed 15 mg/kg to avoid toxicity.

Incorrect. Pediatric defibrillation starts at 2 J/kg to deliver an effective shock safely, increasing to 4 J/kg if needed.

Incorrect. Early administration of epinephrine within 2 minutes improves outcomes in pediatric cardiac arrest.

Incorrect. A compression rate of 100-120 per minute optimizes perfusion while preventing rescuer fatigue.

Incorrect. IV access is the preferred route for drug delivery during resuscitation, ensuring rapid and reliable administration.

Incorrect. A 20 mL/kg bolus of isotonic crystalloid is recommended for managing septic shock in children.

Incorrect. Neonatal hypovolemic shock is managed with smaller boluses of 10 mL/kg to avoid overloading the circulatory system.

Incorrect. Providing 10 breaths per minute ensures adequate oxygenation without causing hyperventilation during CPR with an advanced airway.

Incorrect. For cardiogenic shock, smaller fluid boluses of 5-10 mL/kg are preferred to avoid fluid overload due to poor cardiac function.

Incorrect. ROSC refers to the resumption of effective blood circulation and detectable pulse following cardiac arrest.

Incorrect. Hyperglycemia is not listed as one of the reversible causes of cardiac arrest (H's and T's).